arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Elicio Therapeutics, Inc.

ELTX Health Care Biotechnology: Pharmaceutical Preparations
$1.93
▲ +15.6% Today
as of Oct 23, 13:02 ET
Last 30 days -4.25% Sep 14 → Oct 23
$1.51 $1.64 $1.77 $1.91 $2.04 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.68
High
$1.97
Low
$1.67
Volume
$515,618
Avg Vol
$553,197
Mkt Cap
$50M
P/E (TTM)
—
Beta
—
52w High
$16.00
52w Low
$1.44
Div Yield
—
Shares Out
$22M

Recent Press Releases & News last 60 days · 3 items

Sep 24 · 12:00 PR GlobeNewswire
Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026
Sep 24 · 11:36 MT Newswires
B. Riley Adjusts Price Target on Elicio Therapeutics to $8 From $27, Keeps Buy Rating
Aug 31 · 12:00 PR GlobeNewswire
Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference

ELTX earnings at a glance

The options market is pricing a move of about ±270.7% after the report, a range of roughly -$3.29 to $7.15 from today's $1.93. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±10.3% on average; after the most recent report on May 11, 2026 it moved +17.2%. That means options currently expect more movement than ELTX has typically delivered. ELTX beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 23%. The share price of $1.93 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.44
$16
3% of range
Avg surprise (last 4)
-13.7%
Avg reaction (last 2)
+10.3%
100% positive
Latest IV / EM
2292%
EM ±270.7% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-24.77$-18.68$-12.60$-6.52$-0.43 Actual $-24.77Actual $-2.61Actual $-1.27Actual $-1.15Actual $-0.64Actual $-1.39Actual $-0.87Est $-0.67Actual $-0.66Est $-0.69Actual $-0.60Est $-0.62Actual $-0.65Est $-0.49Actual $-0.43 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-19M$-16M$-14M$-11M$-9M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.43 — — — — financials
Mon May 11, 2026Mar/2026 $-0.65 $-0.49 -32.6% +25.3% +17.2% earnings
Thu Nov 13, 2025Sep/2025 $-0.60 $-0.62 +3.2% — — earnings
Thu Aug 7, 2025Jun/2025 $-0.66 $-0.69 +4.3% — — earnings
Tue May 13, 2025Mar/2025 $-0.87 $-0.67 -29.9% — +3.4% earnings
Mon Sep 30, 2024Sep 2024 $-1.39 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.64 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.15 — — — — financials
Sat Sep 30, 2023Sep 2023 $-1.27 — — — — financials
Fri Jun 30, 2023Jun 2023 $-2.61 — — — — financials
Fri Mar 31, 2023Mar 2023 $-24.77 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-10M$-11M—$-8M$-10M$-11M—$-10M
Net income$-8M$-12M—$-10M$-11M$-11M—$-19M
EPS (diluted)$-0.43$-0.65—$-0.60$-0.66$-0.87—$-1.39

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$23M$15M$19M$21M$22M$18M$18M$26M
Inventory————————
Total current assets$25M$16M$19M$21M$23M$21M$21M$31M
Total assets$31M$23M$26M$28M$30M$28M$28M$38M
Long-term debt$10M$9M$9M$10M$9M—$20M—
Total liabilities$23M$24M$24M$24M$28M$19M$39M$57M
Total equity$8M$-1M$2M$4M$2M$9M$-11M$-19M

Implied volatility — last 90 days

74%628%1183%1737%2291% Jun 07 — IV 294% · EM ±40.7%Jun 08 — IV 267% · EM ±35.2%Jun 09 — IV 264% · EM ±33.1%Jun 10 — IV 244% · EM ±28.8%Jun 11 — IV 382% · EM ±42.2%Jun 12 — IV 276% · EM ±28.3%Jun 15 — IV 474% · EM ±34.3%Jun 16 — IV 153% · EM ±9.0%Jun 17 — IV 1036% · EM ±43.3%Jun 19 — IV 259% · EM ±57.1%Jun 22 — IV 135% · EM ±28.1%Jun 23 — IV 187% · EM ±38.3%Jun 24 — IV 352% · EM ±70.5%Jun 25 — IV 210% · EM ±41.2%Jun 26 — IV 186% · EM ±35.5%Jun 29 — IV 416% · EM ±73.8%Jun 30 — IV 460% · EM ±79.3%Jul 01 — IV 143% · EM ±23.9%Jul 02 — IV 175% · EM ±28.3%Jul 03 — IV 184% · EM ±28.7%Jul 06 — IV 500% · EM ±69.3%Jul 07 — IV 254% · EM ±33.6%Jul 08 — IV 741% · EM ±92.8%Jul 09 — IV 674% · EM ±79.6%Jul 10 — IV 806% · EM ±89.1%Jul 13 — IV 1098% · EM ±91.7%Jul 20 — IV 289% · EM ±68.3%Jul 21 — IV 112% · EM ±26.1%Jul 22 — IV 119% · EM ±27.2%Jul 23 — IV 133% · EM ±29.8%Jul 24 — IV 128% · EM ±28.3%Jul 27 — IV 192% · EM ±40.0%Jul 28 — IV 145% · EM ±29.7%Jul 29 — IV 181% · EM ±36.3%Jul 31 — IV 191% · EM ±36.6%Aug 03 — IV 375% · EM ±66.4%Aug 04 — IV 142% · EM ±24.5%Aug 05 — IV 150% · EM ±25.1%Aug 06 — IV 162% · EM ±26.3%Aug 07 — IV 194% · EM ±30.4%Aug 10 — IV 838% · EM ±116.1%Aug 11 — IV 275% · EM ±36.3%Aug 12 — IV 300% · EM ±37.6%Aug 13 — IV 336% · EM ±39.7%Aug 14 — IV 293% · EM ±32.4%Aug 17 — IV 496% · EM ±41.4%Aug 18 — IV 1911% · EM ±138.3%Aug 19 — IV 622% · EM ±36.7%Aug 24 — IV 273% · EM ±57.0%Aug 25 — IV 269% · EM ±55.0%Aug 26 — IV 260% · EM ±52.0%Aug 27 — IV 266% · EM ±52.0%Sep 03 — IV 74% · EM ±12.0%Sep 08 — IV 129% · EM ±17.0%Sep 09 — IV 136% · EM ±17.0%Sep 11 — IV 375% · EM ±41.5%Sep 16 — IV 1339% · EM ±79.1%Sep 17 — IV 1863% · EM ±77.8%Sep 21 — IV 302% · EM ±63.1%Sep 22 — IV 327% · EM ±66.8%Sep 23 — IV 347% · EM ±69.5%Sep 24 — IV 278% · EM ±54.5%Sep 25 — IV 398% · EM ±76.1%Sep 28 — IV 1342% · EM ±237.8%Sep 29 — IV 395% · EM ±67.9%Sep 30 — IV 608% · EM ±101.6%Oct 01 — IV 580% · EM ±93.8%Oct 02 — IV 1483% · EM ±231.8%Oct 06 — IV 705% · EM ±93.1%Oct 07 — IV 755% · EM ±94.6%Oct 08 — IV 2292% · EM ±270.7%

Sector peers

DOMH
Dominari Holdings Inc.
$51M $1.77-8.2%
PDSB
PDS Biotechnology Corporation
$51M $1.08-12.5%
SER
Serina Therapeutics, Inc.
$50M $1.73-2.3%
CRVO
CervoMed Inc.
$48M $2.28-2.6%
FLNA
Filana Therapeutics, Inc.
$47M $0.65-2.2%
EDSA
Edesa Biotech, Inc.
$46M $2.70-5.3%

ELTX earnings FAQ

What is ELTX's expected move for earnings?

Options currently price a move of about ±270.7%, or $5.22 per share either way from $1.93.

How does ELTX stock usually react to earnings?

Across the last 2 reports the average next-day move was ±10.3%, up 2 times and down 0 times.

What is ELTX's implied volatility?

ELTX's at-the-money implied volatility is about 23% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in